ADA and ankylosing spondylitis: NSAID (etoricoxib or etoricoxib equivalent) consumption during the trial study of biosimilar adalimumab (Bs-ADA) in the study of patients (n = 50) with symptomatic moderately severe chronic ankylosing spondylitis: a single-arm prospective observational study.